Darwin's Medicine
Routledge (Verlag)
978-1-4724-2071-8 (ISBN)
Through the lens of evolutionary science, Professor Smith explores the speciation of new business models in the Life Sciences Industry. This sophisticated and highly original approach offers insights into:
The mechanisms of evolution in this exceptional industry;
The six great technological and social shifts that are shaping its landscape;
The emergence of 26 distinct, new business models; and
The lessons that enable firms to direct and accelerate their own evolution.
These insights map out the industry’s complex, changing landscape and provide an invaluable guide to those firms seeking to survive and thrive in this dynamic market.
The book is essential reading for anyone working in or studying the pharmaceutical, medical technology and related sectors. It provides a unique and novel way of making sense of the transformation we can see going on around us and a practical, focused approach to managing a firm’s evolutionary trajectory.
Professor Brian D. Smith began his career as a research chemist in a pharmaceutical R&D lab and then spent 20 years in technical and marketing roles before becoming an academic, author and adviser. Working at The University of Hertfordshire and SDA Bocconi, two of Europe's leading business schools, his research focuses on strategy creation and implementation in pharmaceutical and medical technology markets. Brian also runs a specialist consultancy that advises many of the world's largest companies in this sector. He is editor of the Journal of Medical Marketing, has written and co-written three major books, including The Future of Pharma (Gower, 2011), and published many practitioner articles - all of which can be seen at www.pragmedic.com.
Part 1: The Future of Pharma - Reprise
1. Introduction and an Invitation to Skip a Chapter
2. An Important Industry at Risk
3. The Best Idea Anyone Has Ever Had
4. The Biologists Got There First
5. Applying Evolutionary Theory to the Pharmaceutical and Medical Technology Sectors
6. Explaining the Industry’s Past
7. Predicting the Future of Pharma and Medtech
8. Practical Implications for an Evolving Industry
9. Watching the Future Unfold
Part 2: An Immeasurably Superior Power
10. Introduction: The Emergent Pressures of Selection
11. Selection Pressures Emerging from the Social Environment
12. Selection Pressures Emerging from the Technological Environment
13. Asking the Right Questions
Part 3: Evolution is Cleverer Than You Are
14. Introduction: Orgel’s Second Law
15. Technological Innovator Species Emerging in the Government Payer Habitat
16. Technological Innovator Species Emerging in Patient Payer Habitats
17. Operationally Excellent Species Emerging in the Government Payer Habitat
18. Operationally Excellent Species Emerging in Patient Payer Habitats
19. Customer Intimate Species Emerging in the Government Payer Habitat
20. Customer Intimate Species Emerging in Patient Payer Habitats
21. A Big Bang of Life Science Business Models
Part 4: Guiding the Blind Watchmaker
22. Introduction: From Description to Prescription
23. Which Fitness Peak(s) Should We Climb?
24. What Capabilities Does Our New Business Model Need?
25. How Should We Design a Capable Holobiont?
26. How Do We Build Our Core Capabilities?
| Erscheinungsdatum | 24.01.2017 |
|---|---|
| Zusatzinfo | 13 Tables, black and white; 56 Line drawings, black and white; 16 Halftones, black and white |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 174 x 246 mm |
| Gewicht | 690 g |
| Themenwelt | Medizin / Pharmazie ► Pharmazie |
| Technik | |
| Wirtschaft ► Betriebswirtschaft / Management ► Unternehmensführung / Management | |
| Wirtschaft ► Volkswirtschaftslehre | |
| ISBN-10 | 1-4724-2071-3 / 1472420713 |
| ISBN-13 | 978-1-4724-2071-8 / 9781472420718 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
